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Abstract Thrombin is a multifunctional enzyme involved in 
coagulation, cell modulation and inflammation. We recently 
reported a novel membrane-associated prothrombin activator, 
abbreviated as MAP A, found in cultured fibroblasts and glial cell 
lines. In this study, we examined the physiological role of this 
enzyme. MAPA-like activity was detected in the liver, kidney, 
lung and heart but not in the spleen or brain in normal mice. To 
examine whether MAPA participates in biological reactions, 
hepatic and renal injury were induced by administration of CC14 
and HgCl2 , respectively. MAPA-like activity was specifically 
increased in the injured tissues: the activity was elevated by 
about 100-fold in 48 h in the liver and increased by about 5-fold 
in 12 h in the kidney. Their enzymatic properties were the same 
as those of MAPA in 8C feline kidney fibroblast cells. 
Phospholipids are required for activation of prothrombin by 
MAPA obtained from both 8C cells and tissues. These results 
suggest that MAPA activates prothrombin on the cell surface in 
injured tissue and participates in inflammation and regeneration 
associated with tissue injury. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Thrombin regulates a number of cellular reactions linked to 
inflammation, wound healing, development and differentia-
tion [1], in addition to hemostasis and thrombosis. Thrombin 
affects these cells via thrombin receptors [2]. Although it was 
believed that its zymogen, prothrombin, is synthesized in the 
liver alone and circulated in the bloodstream, recent studies 
revealed that m R N A s encoding both prothrombin and throm-
bin receptor are expressed in the central nervous system [3,4]. 
Thrombin receptor is widely expressed in cells separated from 
the bloodstream such as fibroblasts, neurons, and astrocytes 
[4,5]. A potent thrombin inhibitor, protease nexin-1 (PN-1), is 
also expressed in extravascular regions [6,7]. These observa-
tions strongly suggest that thrombin regulates biological reac-
tions not only in the bloodstream but also in other tissues. 
However, the mechanism of activation of prothrombin to 
thrombin remains unknown in these areas separated from 
the bloodstream. We recently reported a novel membrane-as-
sociated prothrombin activator (MAPA) that is expressed on 
the surface of various cell lines such as 8C (feline kidney 
fibroblast), M D C K (canine kidney epithelial-like) and T98G 
(human glioblastoma) in culture [8]. Here we show for the first 
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time that M A P A activity is detected in the normal and injured 
murine tissues and the activation of prothrombin by M A P A is 
specifically dependent upon phosphatidylserine. 
2. Materials and methods 
2.1. Materials 
L-cx-Phosphatidylcholine (PC) from egg yolk, L-a-phosphatidyletha-
nolamine (PE) from egg yolk, and L-a-phosphatidyl-L-serine (PS) 
from bovine brain, all >98% pure, and bovine serum albumin 
(BSA) were from Sigma. /7-Amidinophenylmethanesulfonyl fluoride 
(p-APMSF) was obtained from Calbiochem. Diisopropyl fluorophos-
phate (DFP) was purchased from Wako (Osaka, Japan). Superdex 
200 pg was from Pharmacia. Boc-Val-Pro-Arg-p-nitroanilide 
(VPR-pNA) was from Seikagaku Kogyo (Tokyo, Japan). 
2.2. Proteins 
The following proteins were prepared according to published meth-
ods: human rx-thrombin [9], human prothrombin [10], bovine pro-
thrombin fragment-1 [11], and bovine antithrombin III [12]. All of 
these proteins were homogeneous as judged by SDS-PAGE. 
2.3. Preparation of phospholipid vesicles 
Phospholipids in chloroform were mixed and evaporated under a 
stream of nitrogen gas. The residues were suspended in 50 mM Tris-
buffered saline (TBS) and dispersed by sonication. 
2.4. Assays for MAPA activity 
In a typical assay, 90 ul aliquots of 1 uM human prothrombin in 
TBS containing 5 mM CaCl2 and 1 mg/ml BSA were incubated with 
samples at 37°C for 20 min in 96-well microtiter plates. Then, the 
samples were mixed with 10 ul of 2.5 mM VPR-pNA. The initial 
rate of /;-nitroanilme liberation was monitored at 405 nm with a 
kinetic plate reader (Well reader SK-601, Seikagaku Kogyo). The 
activity of the enzyme giving an absorbance of 0.5 at 5 min under 
these conditions was denned simply as 1 unit. 
2.5. Preparation of plasma membranes from normal and injured tissues 
Hepatic and renal injury were induced according to the published 
methods [13,14]. Young adult female ddY mice weighing 18-24 g were 
used in all experiments. Three mice were treated for each period. 
Hepatic injury was induced by intraperitoneal injection of 1 ml of 
20% CCI4 in olive oil/100 g mouse. Renal injury was induced by 
subcutaneous injection of 0.6 mg HgCl2/100 g mouse. After appro-
priate periods, tissues were removed and minced. Control mice were 
administrated only olive oil or saline. The livers and kidneys were 
removed and minced after 0 and 48 h. Then, the tissues were homo-
genized in Tris-buffered saline (TBS; 50 mM Tris-HCl, 100 mM 
NaCl, pH 8.0) with a motor-driven Teflon homogenizer. The homo-
genates were treated with 1 mM DFP and 0.1 mM p-APMSF for 1 h, 
then centrifuged at lOOOOOXg for 60 min to remove excess inhibitors 
and soluble proteins. The pellets were suspended in TBS and assayed 
for MAPA activity. 
2.6. Cell culture 
8C feline kidney fibroblast cells were maintained in plastic cul-
ture dishes (Iwaki, Tokyo, Japan) in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% fetal bovine serum and 
70 ug/ml kanamycin in a humidified atmosphere of 95%> air and 5%> 
C0 2 at 37°C, and cells were transferred after trypsinization every 5-6 
days. 
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2.7. Solubilization and gel filtration 
8C cells were rinsed twice with TBS and cells were scraped off the 
dishes. Harvested cells were suspended in TBS and the plasma mem-
brane fractions were prepared as described [8]. MAPA was extracted 
and fractionated as follows. The plasma membrane fractions contain-
ing 100 pg protein were homogenated in the presence of 1% CHAPS, 
incubated for 1 h on ice, and then centrifuged at 100 000 Xg for 60 
min. Then, the supernatant was applied to a Superdex 200 pg column 
(2.6x60 cm) equipped with a fast protein liquid chromatography 
system (Pharmacia) that had been pre-equilibrated with TBS contain-
ing 0.3% CHAPS and eluted with the same buffer at a flow rate of 
3 ml/min. Fractions (3 ml) were collected and subjected to the assay 
for MAPA activity. These procedures were all performed at 4°C. 
3. Results 
3.1. Detection of MAPA activity in murine liver and kidney 
Since the membrane-associated prothrombin activator 
(MAPA) activity has been detected in several cell lines derived 
from kidney fibroblasts and glioma cells, we examined 
whether similar MAPA-like activity is present in the plasma 
membrane fractions of the kidney and other organs. Murine 
tissues of the liver, kidney, lung and heart had MAPA-like 
activities, whereas no activity of the enzyme was detected in 
other tissues such as the spleen and brain (Fig. 1). The activity 
detected in the liver was about 1/10 of that of 8C based on the 
amount of protein in the lysates. The properties of the enzyme 
detected in the kidney were characterized in detail. The activ-
ity detected in murine tissues was recovered mainly in the 
plasma membrane fraction. The activation derivatives and 
fragments generated by incubation of prothrombin with plas-
ma membranes of the kidney were indistinguishable from 
those generated by incubation with plasma membrane frac-
tions of 8C on SDS-PAGE. Activation of prothrombin was 
dependent on Ca2+ ions. The enzyme had a similar Km value 
for prothrombin (0.17 uM), compared with that of the 8C-
enzyme (0.20 uM). The inhibitors had essentially identical 
effects to the enzyme of the kidney. For example, diwopropyl 
fluorophosphate (10 mM), ^-amidinophenylmethane-sulfonyl 
fluoride (1 mM), dansyl-Glu-Gly-Arg-chloromethyl ketone 
(1 uM), benzamidine (10 mM), pepstatin (1 mM), and iodoa-
cetamide (10 mM) could not abolish the activity. On the other 
hand, exposure of the plasma membrane fraction to EDTA 
(1 mM) resulted in irreversible loss of the activity. Thus, the 
MAPA-like activity found in the murine kidney was essen-
tially the same as that in the cultured cell lines. 
3.2. Increase of MAPA activity in hepatic or renal injured 
murine tissues 
Hepatic or renal injury was induced in mice by intraperito-
neal injection of CCI4 or subcutaneous injection of HgCl2. 
Livers and kidneys were excised at various times after admin-
istration of CCI4 to induce hepatic injury and MAPA activ-
ities of plasma membrane fractions were analyzed. MAPA 
activity of control murine tissues did not change following 
administration of olive oil (data not shown). MAPA-like ac-
tivity of the liver rapidly increased to about 100-fold in 48 h 
compared with controls (Fig. 2A). However, MAPA-like ac-
tivity of the kidney did not change after hepatic injury (Fig. 
2B). Next, mice were treated with HgCl2, and MAPA activity 
was analyzed in the liver and kidney after renal injury. MAPA 
activity of control murine tissues also did not change follow-
ing administration of saline (data not shown). MAPA-like 
activity of the kidney was increased by about 5-fold in 12 h 
3000 
Fig. 1. Distribution of MAPA activity in normal murine tissues. 
Murine tissues were removed, minced, washed in TBS, and lysed by 
freezing/thawing. The lysates were homogenized with a Teflon ho-
mogenizer. The homogenates were assayed for MAPA activity 
(» = 3) after treatment with p-APMSF and DFP. A: Total MAPA 
activity (units/organ). B: Specific MAPA activity (U/mg protein). 
compared with controls, while the enzymatic activity in the 
liver did not change after renal injury (Fig. 2). 
Enzymatic properties of the MAPA-like activities in both 
injured tissues were compared with those of 8C cells. These 
enzymatic properties were indistinguishable from those in the 
tissues and cell lines, indicating that an enzyme similar to 
MAPA detected in 8C is induced in both liver and kidney 
by tissue injury. 
3.3. Requirement of phospholipids for the MAPA activity of 
8C cells 
To isolate and characterize MAPA of the 8C plasma mem-
brane fraction, the solubilized plasma membrane fraction of 
8C was applied to a column of Superdex 200 pg. The results 
are shown in Fig. 3. Little MAPA activity was detected in any 
fraction over a 20 min incubation period. Low activity of 
MAPA was detected in the fraction C even after 60 min 
pre-incubation with prothrombin. Total MAPA activity re-
covered from the column was less than 1% of that of the 
initial solubilized plasma membrane used. This low recovery 
suggested that an unknown factor(s) required for the activa-
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Fig. 2. Induction of MAPA activity by tissue injury. MAPA activity in the liver (A) and kidney (B) after hepatic or renal injury. Hepatic injury 
was induced by intraperitoneal injection of 1 ml of 20% CCI4 in olive oil/lOO g mouse (•). Renal injury was induced by subcutaneous injection 
of 0.6 mg HgCVlOO g mouse (O)- Tissues were removed at each period and homogemzed, then centrifuged at lOOOOOXg for 60 min. MAPA 
activities of homogenates were assayed after treatment with /7-APMSF and DFP. 
tion of prothrombin by MAPA may have been separated by 
this column. To test this hypothesis, reconstitution experi-
ments with fraction C and other fractions were performed 
under the conditions described in the Methods section. Strong 
MAPA activity appeared only in the combined mixture of 
fraction C and D, indicating that both fractions are essential 
for development of MAPA activity. Activity in fraction D was 
not abolished by heat treatment (80°C for 30 min) and was 
extracted with 1:1 methanol/chloroform solution. These re-
sults clearly indicated that fraction D contained phospholipid 
vesicles from the plasma membrane. Thus, we examined the 
effects of phospholipids on the activation of prothrombin by 
MAPA. Prothrombin was activated by MAPA in fraction C 
in the presence of various concentrations of phospholipid 
vesicles (Fig. 4A). The presence of phospholipid vesicles was 
indispensable for the activation of prothrombin by MAPA. 
The activation rate reached a maximum at about 100 |J,M 
phospholipid vesicles. We next investigated the effects of com-
position of the phospholipid vesicles. Prothrombin activation 
was measured in the presence of phospholipid vesicles of var-
ious compositions (Fig. 4B), and phosphatidylserine was 
found to be essential for activation of prothrombin by 
MAPA. The increase in the activation rate was dependent 
on the proportion of phosphatidylserine in the vesicles. No 
activation of prothrombin was observed in the absence of 
phosphatidylserine in the vesicles even in the presence of 
phosphatidylcholine or phosphatidylcholine/phosphatidyleth-
anolamine, indicating that MAPA-mediated prothrombin ac-
tivation is specifically dependent upon phosphatidylserine. 
When the proportion of phosphatidylserine was varied in 
the vesicles, a pronounced leftward shift of the required phos-
phatidylserine proportion was observed in the presence of 
phosphatidylethanolamine. 
4. Discussion 
We previously reported that some culture cell lines have 
membrane-associated prothrombin activator on their surface 
[8]. We showed here the existence of MAPA activity in normal 
tissues in addition to culture cell lines. The enzymatic proper-
ties in tissue(s) are essentially identical to those of culture cell 
lines, indicating that MAPA activity is not unique to culture 
cell lines but also exists in vivo. This can be explanation by 
the necessity of supply of thrombin to cells separated from the 
bloodstream such as fibroblasts. Recently, it was clearly 
shown that prothrombin and protease nexin-1 (PN-1) were 
synthesized locally and thrombin activity was increased with 
sciatic nerve injury [15]. The present study showed that 
MAPA induced in hepatic or renal injury could activate pro-
thrombin to thrombin both in hepatic and renal injuries. 
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Fig. 3. Elution profile of solubilized 8C plasma membranes with gel 
filtration. 8C plasma membrane fraction was solubilized with 1% 
CHAPS for 1 h and centrifuged. The supernatants were applied to 
a Superdex 200 pg column. Fractions (10 ul) were incubated with 
prothrombin in the presence of 5 mM Ca2+ and 2.5 mM VPR-pNA 
and 1 mg/ml BSA in 90 ul TBS for 1 h at 37°C. Then, the absorb-
ance was measured at 405 nm (•). 
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Fig. 4. Requirement of phospholipids for MAPA activity. A: MAPA activity was analyzed in the presence of the indicated concentrations of 
phospholipid vesicles. Aliquots of 10 ul of gel-filtrated fraction C were incubated in the presence of 5 mM Ca2+, 1 uM prothrombin and the 
indicated concentrations of phospholipids vesicles. Phospholipids vesicles contained 25% PS and the remainder was PC. B: Effects of phospho-
lipids on MAPA activity. Aliquots of 10 ul of gel-filtrated fraction C were assayed in the presence of 100 uM phospholipids vesicles. Phospho-
lipids vesicles contained PS at the indicated percentages and contained (•) or lacked (o) 50% PE. The remainder was PC. 
HGF/scatter factor is well known to play a critical role in 
regeneration of the liver and kidneys [16]. HGF/scatter factor 
is activated by HGF activator (HGFA) when the tissues are 
injured. HGFA is also produced from an inactive precursor, 
and the precursor of HGFA is activated by thrombin [17]. 
Since MAPA activity is specifically increased in injured tis-
sues, the level of thrombin would be increased in injured tis-
sues. Thus, MAPA is most likely to participate in the gener-
ation of thrombin in the injured tissues. Although we have no 
data to explain whether thrombin generated by MAPA acti-
vates the HGFA and/or thrombin receptor, the results of the 
present study suggest that MAPA may participate in regener-
ation of injured tissues in consideration of the diverse biolog-
ical reactions of thrombin. 
The results of recombination experiments show that the 
activation of prothrombin by MAPA requires phospholipid 
vesicles. Phosphatidylserine is a crucial component of the 
phospholipid vesicles. Some coagulation factors activate their 
substrates bound on phospholipids, especially phosphathidyl-
serine [18]. Recently, it was found that phosphatidylethanol-
amine also enhances the reaction rates of coagulation/antico-
agulation factors [19,20]. However, the activation of 
prothrombin by prothrombinase complex is not affected by 
phosphatidylethanolamine [19]. These observations support 
the hypothesis that MAPA is not the same as the prothrom-
binase complex. Phosphatidylserine is exposed on the outer 
leaflet at inflammation, while it is present in the inner leaflet 
[21,22]. The exposure of phosphatidylserine in the outer leaflet 
is responsible for the regulation of coagulant activity on the 
surface of platelets and endothelial cells. A similar mechanism 
could occur in other cells isolated from the bloodstream, and 
phosphatidylserine could regulate the thrombin generation by 
MAPA associated with injury. 
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